Why African Americans Don’t Always Get The Latest Multiple Myeloma Treatments
BlackDoctor.org’s “Ask the Expert” series brings the nation’s leading health experts directly to viewers. In this video, Dr. Craig Cole, Hematologist and Assistant Professor at University of Michigan, discusses multiple myeloma.
[bc_video video_id=”5745339630001″ account_id=”5045163367001″ player_id=”HkKfBWB1x” embed=”in-page” padding_top=”56%” autoplay=”” min_width=”0px” max_width=”640px” width=”100%” height=”100%”]
So, decades ago, it didn’t really matter what race you were with myeloma, it was bad. As the research has gone on and there have been new drugs that have come out for myeloma, a lot of that research has been done in Caucasians and not African Americans. And so, as a research has gone on we have found out what drugs work well with Caucasians, not so much with African-Americans because they haven’t been involved in clinical trials. So, that was the start of the disparity.
The current disparity lies with …